Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
Hosted on MSN46m
FDA awards GSK breakthrough status for relapsed osteosarcoma treatment
"FDA awards GSK breakthrough status for relapsed osteosarcoma treatment" was originally created and published by ...
Popular drink found to be contaminated with harmful chemical
A popular drink — one widely believed to be “pure” — houses potentially harmful chemicals. The Hill reports how a recent analysis from the Pesticide Action Network Europe found mineral water sold ...
Is bird flu the next pandemic? What to know after the first H5N1 death in the US
With reports of the first human death from bird flu in the US, some Americans are feeling an uncomfortable flashback to the ...
Kamada Ltd.: Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
Annual Guidance of $178 - $182 Million in Revenue and $38 - $42 Million of Adjusted EBITDA, Representing Year-Over-Year Increase of 13% in Revenues and 19% in Adjusted EBITDA Based on ...